openPR Logo
Press release

Investigation announced for Investors in MutualFirst Financial, Inc. (NASDAQ: MFSF) over Takeover

11-04-2019 10:09 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of investors of MutualFirst Financial, Inc. (NASDAQ: MFSF) in connection with the proposed takeover.

An investigation on behalf of investors of MutualFirst Financial, Inc. (NASDAQ: MFSF) in connection with the proposed takeover.

An investigation on behalf of investors, who currently hold shares of MutualFirst Financial, Inc. (NASDAQ: MFSF), was announced concerning whether the takeover of MutualFirst Financial, Inc. is unfair to NASDAQ: MFSF stockholders.

Investors who purchased shares of MutualFirst Financial, Inc. (NASDAQ: MFSF) and currently hold any of those NASDAQ: MFSF shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain officers and directors of MutualFirst Financial, Inc. breached their fiduciary duties owed to NASDAQ: MFSF investors in connection with the proposed acquisition.

Muncie, IN based MutualFirst Financial, Inc. operates as the bank holding company for MutualBank that provides various financial services in the United States.

On October 29, 2019, Northwest Bancshares, Inc., (NASDAQ: NWBI) and MutualFirst Financial, Inc., ("MutualFirst") (NASDAQ: MFSF) announced the signing of a merger agreement pursuant to which Northwest will acquire MutualFirst, the Muncie, Indiana-based holding company and parent of MutualBank, in an all-stock transaction valued at $39.89 per share (based on Northwest's 15-day volume weighted average closing stock price ending on October 23, 2019), or approximately $346 million in the aggregate.

However, given that all of the directors and certain executive officers of MutualFirst Financial, Inc have already entered into voting agreements with Northwest Bancshares, Inc pursuant to which they have agreed to vote their shares in favor of the transaction, the investigation concerns whether the offer is unfair to MutualFirst Financial, Inc. (NASDAQ: MFSF stockholders. More specifically, the investigation concerns whether the MutualFirst Financial, Inc. (NASDAQ: MFSF Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.

MutualFirst Financial, Inc. reported that its annual Total Tevenue rose from $64.65 million in 2017 to $80.38 million in 2018 and that its Net Income increased from $12.31 million in 2017 to $18.86 million in 2018.

Shares of MutualFirst Financial, Inc. (NASDAQ: MFSF) closed on November 4, 2019, at $39.85 per share.

Those who are current investors in MutualFirst Financial, Inc. (NASDAQ: MFSF) shares have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in MutualFirst Financial, Inc. (NASDAQ: MFSF) over Takeover here

News-ID: 1860915 • Views:

More Releases from Shareholders Foundation

Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: JHX) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements. Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT)
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced. Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherapeutics (NASDAQ: MLTX)
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements. Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc. Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -

All 5 Releases